Index by author

November 01 1998; volume 21 issue 11

A

  1. Aarons, J H

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  2. Abbott, C A

    1. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy.
      J E Shaw, C H van Schie, A L Carrington, C A Abbott and A J Boulton
      Diabetes Care 1998 Nov; 21 (11): 1955-1959. https://doi.org/10.2337/diacare.21.11.1955

  3. Adachi, M

    1. Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
      K Kashiwazaki, T Hirano, G Yoshino, M Kurokawa, H Tajima and M Adachi
      Diabetes Care 1998 Nov; 21 (11): 2016-2020. https://doi.org/10.2337/diacare.21.11.2016

  4. Aguilar-Salinas, C A

    1. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
      F J Gómez-Pérez, C A Aguilar-Salinas, J C López-Alvarenga, J Perez-Jauregui, L E Guillen-Pineda and J A Rull
      Diabetes Care 1998 Nov; 21 (11): 1886-1888. https://doi.org/10.2337/diacare.21.11.1886

  5. Alessis, C

    1. Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
      V Lassmann-Vague, M SanMarco, P J LeJeune, C Alessis, P Vague and P Belicar
      Diabetes Care 1998 Nov; 21 (11): 2041-2044. https://doi.org/10.2337/diacare.21.11.2041

  6. Allannic, H

    1. Clinical and statistical evaluation of self-monitoring blood glucose meters.
      J Y Poirier, N Le Prieur, L Campion, I Guilhem, H Allannic and D Maugendre
      Diabetes Care 1998 Nov; 21 (11): 1919-1924. https://doi.org/10.2337/diacare.21.11.1919

  7. Andrade, R J

    1. Acarbose-associated hepatotoxicity.
      R J Andrade, M Lucena, J L Vega, M Torres, F J Salmerón, V Bellot, M D García-Escaño and P Moreno
      Diabetes Care 1998 Nov; 21 (11): 2029-2030. https://doi.org/10.2337/diacare.21.11.2029

  8. André, P

    1. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
      M A Charles, P Morange, E Eschwège, P André, P Vague and I Juhan-Vague
      Diabetes Care 1998 Nov; 21 (11): 1967-1972. https://doi.org/10.2337/diacare.21.11.1967

B

  1. Bangstad, H J

    1. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
      T J Berg, J T Clausen, P A Torjesen, K Dahl-Jørgensen, H J Bangstad and K F Hanssen
      Diabetes Care 1998 Nov; 21 (11): 1997-2002. https://doi.org/10.2337/diacare.21.11.1997

  2. Barry, D G

    1. Plasma homocysteine concentrations in patients with type 1 diabetes.
      C C Cronin, J M McPartlin, D G Barry, J B Ferriss, J M Scott and D G Weir
      Diabetes Care 1998 Nov; 21 (11): 1843-1847. https://doi.org/10.2337/diacare.21.11.1843

  3. Bax, J J

    1. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
      A Elhendy, R T van Domburg, D Poldermans, J J Bax, P R Nierop, M L Geleijnse and J R Roelandt
      Diabetes Care 1998 Nov; 21 (11): 1797-1802. https://doi.org/10.2337/diacare.21.11.1797

  4. Bayraktar, M

    1. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study.
      N B Tütüncü, M Bayraktar and K Varli
      Diabetes Care 1998 Nov; 21 (11): 1915-1918. https://doi.org/10.2337/diacare.21.11.1915

  5. Becker, D

    1. Islet cell autoimmunity in white and black children and adolescents with IDDM.
      I M Libman, M Pietropaolo, M Trucco, J S Dorman, R E LaPorte and D Becker
      Diabetes Care 1998 Nov; 21 (11): 1824-1827. https://doi.org/10.2337/diacare.21.11.1824

  6. Belch, J J

    1. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
      T A Elhadd, F Khan, G Kirk, M McLaren, R W Newton, S A Greene and J J Belch
      Diabetes Care 1998 Nov; 21 (11): 1990-1996. https://doi.org/10.2337/diacare.21.11.1990

  7. Belicar, P

    1. Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
      V Lassmann-Vague, M SanMarco, P J LeJeune, C Alessis, P Vague and P Belicar
      Diabetes Care 1998 Nov; 21 (11): 2041-2044. https://doi.org/10.2337/diacare.21.11.2041

  8. Bell, D S

    1. Metformin lowers lipoprotein(a) levels.
      D S Bell and F Ovalle
      Diabetes Care 1998 Nov; 21 (11): 2028. https://doi.org/10.2337/diacare.21.11.2028b
    2. Troglitazone interferes with gemfibrozil's lipid-lowering action.
      D S Bell and F Ovalle
      Diabetes Care 1998 Nov; 21 (11): 2028-2029. https://doi.org/10.2337/diacare.21.11.2028a

  9. Bellot, V

    1. Acarbose-associated hepatotoxicity.
      R J Andrade, M Lucena, J L Vega, M Torres, F J Salmerón, V Bellot, M D García-Escaño and P Moreno
      Diabetes Care 1998 Nov; 21 (11): 2029-2030. https://doi.org/10.2337/diacare.21.11.2029

  10. Berg, T J

    1. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
      T J Berg, J T Clausen, P A Torjesen, K Dahl-Jørgensen, H J Bangstad and K F Hanssen
      Diabetes Care 1998 Nov; 21 (11): 1997-2002. https://doi.org/10.2337/diacare.21.11.1997

  11. Bergeret, A

    1. Consequences of metformin intoxication.
      J D Lalau, C Mourlhon, A Bergeret and C Lacroix
      Diabetes Care 1998 Nov; 21 (11): 2036-2037. https://doi.org/10.2337/diacare.21.11.2036

  12. Bichucher, H

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  13. Bortolotti, A

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  14. Boulton, A J

    1. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy.
      J E Shaw, C H van Schie, A L Carrington, C A Abbott and A J Boulton
      Diabetes Care 1998 Nov; 21 (11): 1955-1959. https://doi.org/10.2337/diacare.21.11.1955

  15. Bretzel, R G

    1. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
      C Meyer, R Grossmann, A Mitrakou, R Mahler, T Veneman, J Gerich and R G Bretzel
      Diabetes Care 1998 Nov; 21 (11): 1960-1966. https://doi.org/10.2337/diacare.21.11.1960

  16. Brodows, R G

    1. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
      R B Goldberg, D Einhorn, C P Lucas, M S Rendell, P Damsbo, W C Huang, P Strange and R G Brodows
      Diabetes Care 1998 Nov; 21 (11): 1897-1903. https://doi.org/10.2337/diacare.21.11.1897

  17. Brun, J F

    1. Association between fibrinogen levels and insulin resistance.
      E Raynaud, J F Brun, A Perez-Martin and J Mercier
      Diabetes Care 1998 Nov; 21 (11): 2040-2041. https://doi.org/10.2337/diacare.21.11.2040

  18. Burch, A

    1. Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
      R Playle, R L Ollerton, F D Dunstan, W D Evans, A Burch, S D Luzio and D R Owens
      Diabetes Care 1998 Nov; 21 (11): 1893-1896. https://doi.org/10.2337/diacare.21.11.1893

  19. Burkert, U

    1. Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
      M Rose, U Burkert, G Scholler, T Schirop, G Danzer and B F Klapp
      Diabetes Care 1998 Nov; 21 (11): 1876-1885. https://doi.org/10.2337/diacare.21.11.1876

  20. Butzner, J D

    1. Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes.
      K A Fraser-Reynolds, J D Butzner, D K Stephure, R A Trussell and R B Scott
      Diabetes Care 1998 Nov; 21 (11): 1985-1989. https://doi.org/10.2337/diacare.21.11.1985

C

  1. Campion, L

    1. Clinical and statistical evaluation of self-monitoring blood glucose meters.
      J Y Poirier, N Le Prieur, L Campion, I Guilhem, H Allannic and D Maugendre
      Diabetes Care 1998 Nov; 21 (11): 1919-1924. https://doi.org/10.2337/diacare.21.11.1919

  2. Carrington, A L

    1. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy.
      J E Shaw, C H van Schie, A L Carrington, C A Abbott and A J Boulton
      Diabetes Care 1998 Nov; 21 (11): 1955-1959. https://doi.org/10.2337/diacare.21.11.1955

  3. Chan, J C

    1. Supplement to the use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes.
      G T Ko, J C Chan and C S Cockram
      Diabetes Care 1998 Nov; 21 (11): 2032-2033. https://doi.org/10.2337/diacare.21.11.2032

  4. Chang, C J

    1. Fasting plasma glucose in screening for diabetes in the Taiwanese population.
      C J Chang, J S Wu, F H Lu, H L Lee, Y C Yang and M J Wen
      Diabetes Care 1998 Nov; 21 (11): 1856-1860. https://doi.org/10.2337/diacare.21.11.1856

  5. Charles, M A

    1. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
      M A Charles, P Morange, E Eschwège, P André, P Vague and I Juhan-Vague
      Diabetes Care 1998 Nov; 21 (11): 1967-1972. https://doi.org/10.2337/diacare.21.11.1967

  6. Chatenoud, L

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  7. Cherubini, V

    1. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
      L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese, P E Gallenga and F Chiarelli
      Diabetes Care 1998 Nov; 21 (11): 2003-2006. https://doi.org/10.2337/diacare.21.11.2003

  8. Chiarelli, F

    1. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
      L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese, P E Gallenga and F Chiarelli
      Diabetes Care 1998 Nov; 21 (11): 2003-2006. https://doi.org/10.2337/diacare.21.11.2003

  9. Clarke, W

    1. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
      B P Kovatchev, D J Cox, L A Gonder-Frederick, D Young-Hyman, D Schlundt and W Clarke
      Diabetes Care 1998 Nov; 21 (11): 1870-1875. https://doi.org/10.2337/diacare.21.11.1870

  10. Clausen, J T

    1. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
      T J Berg, J T Clausen, P A Torjesen, K Dahl-Jørgensen, H J Bangstad and K F Hanssen
      Diabetes Care 1998 Nov; 21 (11): 1997-2002. https://doi.org/10.2337/diacare.21.11.1997

  11. Cockram, C S

    1. Supplement to the use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes.
      G T Ko, J C Chan and C S Cockram
      Diabetes Care 1998 Nov; 21 (11): 2032-2033. https://doi.org/10.2337/diacare.21.11.2032

  12. Colli, E

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  13. conley, M R

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  14. Cooper, R S

    1. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans.
      I S Okosun, R S Cooper, C N Rotimi, B Osotimehin and T Forrester
      Diabetes Care 1998 Nov; 21 (11): 1836-1842. https://doi.org/10.2337/diacare.21.11.1836

  15. Coscelli, C

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  16. Cox, D J

    1. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
      B P Kovatchev, D J Cox, L A Gonder-Frederick, D Young-Hyman, D Schlundt and W Clarke
      Diabetes Care 1998 Nov; 21 (11): 1870-1875. https://doi.org/10.2337/diacare.21.11.1870

  17. Cronin, C C

    1. Plasma homocysteine concentrations in patients with type 1 diabetes.
      C C Cronin, J M McPartlin, D G Barry, J B Ferriss, J M Scott and D G Weir
      Diabetes Care 1998 Nov; 21 (11): 1843-1847. https://doi.org/10.2337/diacare.21.11.1843

  18. Cryer, P E

    1. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
      M T Korytkowski, M Mokan, T F Veneman, A Mitrakou, P E Cryer and J E Gerich
      Diabetes Care 1998 Nov; 21 (11): 1939-1943. https://doi.org/10.2337/diacare.21.11.1939

D

  1. D'Agostino, R B

    1. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
      J T Dubuisson, L E Wagenknecht, R B D'Agostino, S M Haffner, M Rewers, M F Saad, A Laws and D M Herrington
      Diabetes Care 1998 Nov; 21 (11): 1790-1796. https://doi.org/10.2337/diacare.21.11.1790
    2. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
      L E Wagenknecht, R B D'Agostino, S M Haffner, P J Savage and M Rewers
      Diabetes Care 1998 Nov; 21 (11): 1812-1818. https://doi.org/10.2337/diacare.21.11.1812

  2. Dahl-Jørgensen, K

    1. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
      T J Berg, J T Clausen, P A Torjesen, K Dahl-Jørgensen, H J Bangstad and K F Hanssen
      Diabetes Care 1998 Nov; 21 (11): 1997-2002. https://doi.org/10.2337/diacare.21.11.1997

  3. Damsbo, P

    1. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
      R B Goldberg, D Einhorn, C P Lucas, M S Rendell, P Damsbo, W C Huang, P Strange and R G Brodows
      Diabetes Care 1998 Nov; 21 (11): 1897-1903. https://doi.org/10.2337/diacare.21.11.1897

  4. Danzer, G

    1. Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
      M Rose, U Burkert, G Scholler, T Schirop, G Danzer and B F Klapp
      Diabetes Care 1998 Nov; 21 (11): 1876-1885. https://doi.org/10.2337/diacare.21.11.1876

  5. Davis, W S

    1. Gestational diabetes: do lean young caucasian women need to be tested?
      R G Moses, J Moses and W S Davis
      Diabetes Care 1998 Nov; 21 (11): 1803-1806. https://doi.org/10.2337/diacare.21.11.1803

  6. Deepa, R

    1. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
      V Mohan, R Deepa, S P Haranath, G Premalatha, M Rema, N G Sastry and E A Enas
      Diabetes Care 1998 Nov; 21 (11): 1819-1823. https://doi.org/10.2337/diacare.21.11.1819

  7. Della Loggia, G

    1. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
      L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese, P E Gallenga and F Chiarelli
      Diabetes Care 1998 Nov; 21 (11): 2003-2006. https://doi.org/10.2337/diacare.21.11.2003

  8. Dorman, J S

    1. Islet cell autoimmunity in white and black children and adolescents with IDDM.
      I M Libman, M Pietropaolo, M Trucco, J S Dorman, R E LaPorte and D Becker
      Diabetes Care 1998 Nov; 21 (11): 1824-1827. https://doi.org/10.2337/diacare.21.11.1824

  9. Dubuisson, J T

    1. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
      J T Dubuisson, L E Wagenknecht, R B D'Agostino, S M Haffner, M Rewers, M F Saad, A Laws and D M Herrington
      Diabetes Care 1998 Nov; 21 (11): 1790-1796. https://doi.org/10.2337/diacare.21.11.1790

  10. Dunstan, F D

    1. Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
      R Playle, R L Ollerton, F D Dunstan, W D Evans, A Burch, S D Luzio and D R Owens
      Diabetes Care 1998 Nov; 21 (11): 1893-1896. https://doi.org/10.2337/diacare.21.11.1893

E

  1. Eibl, N

    1. Magnesium supplementation in type 2 diabetes.
      N Eibl, C Schnack and G Schernthaner
      Diabetes Care 1998 Nov; 21 (11): 2031-2032. https://doi.org/10.2337/diacare.21.11.2031

  2. Einhorn, D

    1. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
      R B Goldberg, D Einhorn, C P Lucas, M S Rendell, P Damsbo, W C Huang, P Strange and R G Brodows
      Diabetes Care 1998 Nov; 21 (11): 1897-1903. https://doi.org/10.2337/diacare.21.11.1897

  3. Ekstrand, A

    1. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
      C M Forsblom, P H Groop, A Ekstrand, K J Tötterman, T Sane, C Saloranta and L Groop
      Diabetes Care 1998 Nov; 21 (11): 1932-1938. https://doi.org/10.2337/diacare.21.11.1932

  4. Elhadd, T A

    1. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
      T A Elhadd, F Khan, G Kirk, M McLaren, R W Newton, S A Greene and J J Belch
      Diabetes Care 1998 Nov; 21 (11): 1990-1996. https://doi.org/10.2337/diacare.21.11.1990

  5. Elhendy, A

    1. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
      A Elhendy, R T van Domburg, D Poldermans, J J Bax, P R Nierop, M L Geleijnse and J R Roelandt
      Diabetes Care 1998 Nov; 21 (11): 1797-1802. https://doi.org/10.2337/diacare.21.11.1797

  6. Emoto, M

    1. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
      H Taniwaki, Y Nishizawa, T Kawagishi, E Ishimura, M Emoto, T Okamura, Y Okuno and H Morii
      Diabetes Care 1998 Nov; 21 (11): 1848-1855. https://doi.org/10.2337/diacare.21.11.1848

  7. Enas, E A

    1. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
      V Mohan, R Deepa, S P Haranath, G Premalatha, M Rema, N G Sastry and E A Enas
      Diabetes Care 1998 Nov; 21 (11): 1819-1823. https://doi.org/10.2337/diacare.21.11.1819

  8. Erdoğan, G

    1. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan.
      A R Uysal, M F Erdoğan, G Sahin, N Kamel and G Erdoğan
      Diabetes Care 1998 Nov; 21 (11): 2033-2034. https://doi.org/10.2337/diacare.21.11.2033

  9. Erdoğan, M F

    1. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan.
      A R Uysal, M F Erdoğan, G Sahin, N Kamel and G Erdoğan
      Diabetes Care 1998 Nov; 21 (11): 2033-2034. https://doi.org/10.2337/diacare.21.11.2033

  10. Eschwège, E

    1. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
      M A Charles, P Morange, E Eschwège, P André, P Vague and I Juhan-Vague
      Diabetes Care 1998 Nov; 21 (11): 1967-1972. https://doi.org/10.2337/diacare.21.11.1967

  11. Escobar-Jiménez, F

    1. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
      V Sánchez-Margalet, J A Lobón, A González, M L Fernández-Soto, F Escobar-Jiménez and R Goberna
      Diabetes Care 1998 Nov; 21 (11): 1951-1954. https://doi.org/10.2337/diacare.21.11.1951

  12. Evans, W D

    1. Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
      R Playle, R L Ollerton, F D Dunstan, W D Evans, A Burch, S D Luzio and D R Owens
      Diabetes Care 1998 Nov; 21 (11): 1893-1896. https://doi.org/10.2337/diacare.21.11.1893

F

  1. Fedele, D

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  2. Fernández-Soto, M L

    1. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
      V Sánchez-Margalet, J A Lobón, A González, M L Fernández-Soto, F Escobar-Jiménez and R Goberna
      Diabetes Care 1998 Nov; 21 (11): 1951-1954. https://doi.org/10.2337/diacare.21.11.1951

  3. Ferreira, S R

    1. Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group.
      S G Gimeno, S R Ferreira, L J Franco and M Iunes
      Diabetes Care 1998 Nov; 21 (11): 1889-1892. https://doi.org/10.2337/diacare.21.11.1889

  4. Ferriss, J B

    1. Plasma homocysteine concentrations in patients with type 1 diabetes.
      C C Cronin, J M McPartlin, D G Barry, J B Ferriss, J M Scott and D G Weir
      Diabetes Care 1998 Nov; 21 (11): 1843-1847. https://doi.org/10.2337/diacare.21.11.1843

  5. Forrester, T

    1. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans.
      I S Okosun, R S Cooper, C N Rotimi, B Osotimehin and T Forrester
      Diabetes Care 1998 Nov; 21 (11): 1836-1842. https://doi.org/10.2337/diacare.21.11.1836

  6. Forsblom, C M

    1. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
      C M Forsblom, P H Groop, A Ekstrand, K J Tötterman, T Sane, C Saloranta and L Groop
      Diabetes Care 1998 Nov; 21 (11): 1932-1938. https://doi.org/10.2337/diacare.21.11.1932

  7. Franco, L J

    1. Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group.
      S G Gimeno, S R Ferreira, L J Franco and M Iunes
      Diabetes Care 1998 Nov; 21 (11): 1889-1892. https://doi.org/10.2337/diacare.21.11.1889

  8. Fraser-Reynolds, K A

    1. Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes.
      K A Fraser-Reynolds, J D Butzner, D K Stephure, R A Trussell and R B Scott
      Diabetes Care 1998 Nov; 21 (11): 1985-1989. https://doi.org/10.2337/diacare.21.11.1985

  9. Friedmann, R

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  10. Funakoshi, S

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

G

  1. Gallenga, P E

    1. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
      L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese, P E Gallenga and F Chiarelli
      Diabetes Care 1998 Nov; 21 (11): 2003-2006. https://doi.org/10.2337/diacare.21.11.2003

  2. Galun, R

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  3. García-Escaño, M D

    1. Acarbose-associated hepatotoxicity.
      R J Andrade, M Lucena, J L Vega, M Torres, F J Salmerón, V Bellot, M D García-Escaño and P Moreno
      Diabetes Care 1998 Nov; 21 (11): 2029-2030. https://doi.org/10.2337/diacare.21.11.2029

  4. Geleijnse, M L

    1. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
      A Elhendy, R T van Domburg, D Poldermans, J J Bax, P R Nierop, M L Geleijnse and J R Roelandt
      Diabetes Care 1998 Nov; 21 (11): 1797-1802. https://doi.org/10.2337/diacare.21.11.1797

  5. Gerich, J

    1. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
      C Meyer, R Grossmann, A Mitrakou, R Mahler, T Veneman, J Gerich and R G Bretzel
      Diabetes Care 1998 Nov; 21 (11): 1960-1966. https://doi.org/10.2337/diacare.21.11.1960

  6. Gerich, J E

    1. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
      M T Korytkowski, M Mokan, T F Veneman, A Mitrakou, P E Cryer and J E Gerich
      Diabetes Care 1998 Nov; 21 (11): 1939-1943. https://doi.org/10.2337/diacare.21.11.1939

  7. Gilead, L

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  8. Gimeno, S G

    1. Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group.
      S G Gimeno, S R Ferreira, L J Franco and M Iunes
      Diabetes Care 1998 Nov; 21 (11): 1889-1892. https://doi.org/10.2337/diacare.21.11.1889

  9. Goberna, R

    1. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
      V Sánchez-Margalet, J A Lobón, A González, M L Fernández-Soto, F Escobar-Jiménez and R Goberna
      Diabetes Care 1998 Nov; 21 (11): 1951-1954. https://doi.org/10.2337/diacare.21.11.1951

  10. Goldberg, R B

    1. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
      R B Goldberg, D Einhorn, C P Lucas, M S Rendell, P Damsbo, W C Huang, P Strange and R G Brodows
      Diabetes Care 1998 Nov; 21 (11): 1897-1903. https://doi.org/10.2337/diacare.21.11.1897

  11. Gómez-Pérez, F J

    1. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
      F J Gómez-Pérez, C A Aguilar-Salinas, J C López-Alvarenga, J Perez-Jauregui, L E Guillen-Pineda and J A Rull
      Diabetes Care 1998 Nov; 21 (11): 1886-1888. https://doi.org/10.2337/diacare.21.11.1886

  12. Gonder-Frederick, L A

    1. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
      B P Kovatchev, D J Cox, L A Gonder-Frederick, D Young-Hyman, D Schlundt and W Clarke
      Diabetes Care 1998 Nov; 21 (11): 1870-1875. https://doi.org/10.2337/diacare.21.11.1870

  13. González, A

    1. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
      V Sánchez-Margalet, J A Lobón, A González, M L Fernández-Soto, F Escobar-Jiménez and R Goberna
      Diabetes Care 1998 Nov; 21 (11): 1951-1954. https://doi.org/10.2337/diacare.21.11.1951

  14. Greene, S A

    1. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
      T A Elhadd, F Khan, G Kirk, M McLaren, R W Newton, S A Greene and J J Belch
      Diabetes Care 1998 Nov; 21 (11): 1990-1996. https://doi.org/10.2337/diacare.21.11.1990

  15. Groop, L

    1. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
      C M Forsblom, P H Groop, A Ekstrand, K J Tötterman, T Sane, C Saloranta and L Groop
      Diabetes Care 1998 Nov; 21 (11): 1932-1938. https://doi.org/10.2337/diacare.21.11.1932

  16. Groop, P H

    1. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
      C M Forsblom, P H Groop, A Ekstrand, K J Tötterman, T Sane, C Saloranta and L Groop
      Diabetes Care 1998 Nov; 21 (11): 1932-1938. https://doi.org/10.2337/diacare.21.11.1932

  17. Grossmann, R

    1. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
      C Meyer, R Grossmann, A Mitrakou, R Mahler, T Veneman, J Gerich and R G Bretzel
      Diabetes Care 1998 Nov; 21 (11): 1960-1966. https://doi.org/10.2337/diacare.21.11.1960

  18. Guilhem, I

    1. Clinical and statistical evaluation of self-monitoring blood glucose meters.
      J Y Poirier, N Le Prieur, L Campion, I Guilhem, H Allannic and D Maugendre
      Diabetes Care 1998 Nov; 21 (11): 1919-1924. https://doi.org/10.2337/diacare.21.11.1919

  19. Guillen-Pineda, L E

    1. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
      F J Gómez-Pérez, C A Aguilar-Salinas, J C López-Alvarenga, J Perez-Jauregui, L E Guillen-Pineda and J A Rull
      Diabetes Care 1998 Nov; 21 (11): 1886-1888. https://doi.org/10.2337/diacare.21.11.1886

H

  1. Haffner, S M

    1. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
      J T Dubuisson, L E Wagenknecht, R B D'Agostino, S M Haffner, M Rewers, M F Saad, A Laws and D M Herrington
      Diabetes Care 1998 Nov; 21 (11): 1790-1796. https://doi.org/10.2337/diacare.21.11.1790
    2. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
      L E Wagenknecht, R B D'Agostino, S M Haffner, P J Savage and M Rewers
      Diabetes Care 1998 Nov; 21 (11): 1812-1818. https://doi.org/10.2337/diacare.21.11.1812

  2. Halter, J B

    1. Differential effects of BMI on diabetes risk among black and white Americans.
      H E Resnick, P Valsania, J B Halter and X Lin
      Diabetes Care 1998 Nov; 21 (11): 1828-1835. https://doi.org/10.2337/diacare.21.11.1828

  3. Hanssen, K F

    1. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
      T J Berg, J T Clausen, P A Torjesen, K Dahl-Jørgensen, H J Bangstad and K F Hanssen
      Diabetes Care 1998 Nov; 21 (11): 1997-2002. https://doi.org/10.2337/diacare.21.11.1997

  4. Haranath, S P

    1. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
      V Mohan, R Deepa, S P Haranath, G Premalatha, M Rema, N G Sastry and E A Enas
      Diabetes Care 1998 Nov; 21 (11): 1819-1823. https://doi.org/10.2337/diacare.21.11.1819

  5. Heine, R J

    1. Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire.
      F Pouwer, F J Snoek and R J Heine
      Diabetes Care 1998 Nov; 21 (11): 2039. https://doi.org/10.2337/diacare.21.11.2039b

  6. Heinemann, L

    1. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
      L Heinemann, C Weyer, M Rauhaus, S Heinrichs and T Heise
      Diabetes Care 1998 Nov; 21 (11): 1910-1914. https://doi.org/10.2337/diacare.21.11.1910

  7. Heinrichs, S

    1. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
      L Heinemann, C Weyer, M Rauhaus, S Heinrichs and T Heise
      Diabetes Care 1998 Nov; 21 (11): 1910-1914. https://doi.org/10.2337/diacare.21.11.1910

  8. Heise, T

    1. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
      L Heinemann, C Weyer, M Rauhaus, S Heinrichs and T Heise
      Diabetes Care 1998 Nov; 21 (11): 1910-1914. https://doi.org/10.2337/diacare.21.11.1910

  9. Herrington, D M

    1. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
      J T Dubuisson, L E Wagenknecht, R B D'Agostino, S M Haffner, M Rewers, M F Saad, A Laws and D M Herrington
      Diabetes Care 1998 Nov; 21 (11): 1790-1796. https://doi.org/10.2337/diacare.21.11.1790

  10. Hirano, T

    1. Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
      K Kashiwazaki, T Hirano, G Yoshino, M Kurokawa, H Tajima and M Adachi
      Diabetes Care 1998 Nov; 21 (11): 2016-2020. https://doi.org/10.2337/diacare.21.11.2016

  11. Holmes, L

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  12. Holst, J J

    1. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
      M A Nauck, A Sauerwald, R Ritzel, J J Holst and W Schmiegel
      Diabetes Care 1998 Nov; 21 (11): 1925-1931. https://doi.org/10.2337/diacare.21.11.1925

  13. Home, P D

    1. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
      P D Home, A Lindholm, B Hylleberg and P Round
      Diabetes Care 1998 Nov; 21 (11): 1904-1909. https://doi.org/10.2337/diacare.21.11.1904

  14. Huang, W C

    1. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
      R B Goldberg, D Einhorn, C P Lucas, M S Rendell, P Damsbo, W C Huang, P Strange and R G Brodows
      Diabetes Care 1998 Nov; 21 (11): 1897-1903. https://doi.org/10.2337/diacare.21.11.1897

  15. Hylleberg, B

    1. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
      P D Home, A Lindholm, B Hylleberg and P Round
      Diabetes Care 1998 Nov; 21 (11): 1904-1909. https://doi.org/10.2337/diacare.21.11.1904

I

  1. Ingber, A

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  2. Ioffe-Uspensky, I

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  3. Ishimura, E

    1. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
      H Taniwaki, Y Nishizawa, T Kawagishi, E Ishimura, M Emoto, T Okamura, Y Okuno and H Morii
      Diabetes Care 1998 Nov; 21 (11): 1848-1855. https://doi.org/10.2337/diacare.21.11.1848

  4. Isotani, H

    1. Impaired insulin secretion in Japanese diabetic subjects with an A-to-G mutation at nucleotide 8296 of the mitochondrial DNA in tRNA(Lys)
      K Kameoka, H Isotani, K Tanaka, H Kitaoka and N Ohsawa
      Diabetes Care 1998 Nov; 21 (11): 2034-2035. https://doi.org/10.2337/diacare.21.11.2034

  5. Iunes, M

    1. Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group.
      S G Gimeno, S R Ferreira, L J Franco and M Iunes
      Diabetes Care 1998 Nov; 21 (11): 1889-1892. https://doi.org/10.2337/diacare.21.11.1889

  6. Iwasaki, R

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

J

  1. Jacobsen, P

    1. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
      K Rossing, P Jacobsen, P Rossing, E Lauritzen, H Lund-Andersen and H H Parving
      Diabetes Care 1998 Nov; 21 (11): 2007-2015. https://doi.org/10.2337/diacare.21.11.2007

  2. Jovanovic, L

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  3. Juhan-Vague, I

    1. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
      M A Charles, P Morange, E Eschwège, P André, P Vague and I Juhan-Vague
      Diabetes Care 1998 Nov; 21 (11): 1967-1972. https://doi.org/10.2337/diacare.21.11.1967

K

  1. Kamel, N

    1. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan.
      A R Uysal, M F Erdoğan, G Sahin, N Kamel and G Erdoğan
      Diabetes Care 1998 Nov; 21 (11): 2033-2034. https://doi.org/10.2337/diacare.21.11.2033

  2. Kameoka, K

    1. Impaired insulin secretion in Japanese diabetic subjects with an A-to-G mutation at nucleotide 8296 of the mitochondrial DNA in tRNA(Lys)
      K Kameoka, H Isotani, K Tanaka, H Kitaoka and N Ohsawa
      Diabetes Care 1998 Nov; 21 (11): 2034-2035. https://doi.org/10.2337/diacare.21.11.2034

  3. Kashiwazaki, K

    1. Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
      K Kashiwazaki, T Hirano, G Yoshino, M Kurokawa, H Tajima and M Adachi
      Diabetes Care 1998 Nov; 21 (11): 2016-2020. https://doi.org/10.2337/diacare.21.11.2016

  4. Kasuga, A

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

  5. Kawagishi, T

    1. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
      H Taniwaki, Y Nishizawa, T Kawagishi, E Ishimura, M Emoto, T Okamura, Y Okuno and H Morii
      Diabetes Care 1998 Nov; 21 (11): 1848-1855. https://doi.org/10.2337/diacare.21.11.1848

  6. Khan, F

    1. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
      T A Elhadd, F Khan, G Kirk, M McLaren, R W Newton, S A Greene and J J Belch
      Diabetes Care 1998 Nov; 21 (11): 1990-1996. https://doi.org/10.2337/diacare.21.11.1990

  7. Kirk, G

    1. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
      T A Elhadd, F Khan, G Kirk, M McLaren, R W Newton, S A Greene and J J Belch
      Diabetes Care 1998 Nov; 21 (11): 1990-1996. https://doi.org/10.2337/diacare.21.11.1990

  8. Kitaoka, H

    1. Impaired insulin secretion in Japanese diabetic subjects with an A-to-G mutation at nucleotide 8296 of the mitochondrial DNA in tRNA(Lys)
      K Kameoka, H Isotani, K Tanaka, H Kitaoka and N Ohsawa
      Diabetes Care 1998 Nov; 21 (11): 2034-2035. https://doi.org/10.2337/diacare.21.11.2034

  9. Klapp, B F

    1. Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
      M Rose, U Burkert, G Scholler, T Schirop, G Danzer and B F Klapp
      Diabetes Care 1998 Nov; 21 (11): 1876-1885. https://doi.org/10.2337/diacare.21.11.1876

  10. Knopp, R H

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  11. Ko, G T

    1. Supplement to the use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes.
      G T Ko, J C Chan and C S Cockram
      Diabetes Care 1998 Nov; 21 (11): 2032-2033. https://doi.org/10.2337/diacare.21.11.2032

  12. Kobayashi, A

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

  13. Korytkowski, M T

    1. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
      M T Korytkowski, M Mokan, T F Veneman, A Mitrakou, P E Cryer and J E Gerich
      Diabetes Care 1998 Nov; 21 (11): 1939-1943. https://doi.org/10.2337/diacare.21.11.1939

  14. Kovatchev, B P

    1. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
      B P Kovatchev, D J Cox, L A Gonder-Frederick, D Young-Hyman, D Schlundt and W Clarke
      Diabetes Care 1998 Nov; 21 (11): 1870-1875. https://doi.org/10.2337/diacare.21.11.1870

  15. Kurokawa, M

    1. Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
      K Kashiwazaki, T Hirano, G Yoshino, M Kurokawa, H Tajima and M Adachi
      Diabetes Care 1998 Nov; 21 (11): 2016-2020. https://doi.org/10.2337/diacare.21.11.2016

L

  1. Lacroix, C

    1. Consequences of metformin intoxication.
      J D Lalau, C Mourlhon, A Bergeret and C Lacroix
      Diabetes Care 1998 Nov; 21 (11): 2036-2037. https://doi.org/10.2337/diacare.21.11.2036

  2. Lalau, J D

    1. Consequences of metformin intoxication.
      J D Lalau, C Mourlhon, A Bergeret and C Lacroix
      Diabetes Care 1998 Nov; 21 (11): 2036-2037. https://doi.org/10.2337/diacare.21.11.2036

  3. Landoni, M

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  4. LaPorte, R E

    1. Islet cell autoimmunity in white and black children and adolescents with IDDM.
      I M Libman, M Pietropaolo, M Trucco, J S Dorman, R E LaPorte and D Becker
      Diabetes Care 1998 Nov; 21 (11): 1824-1827. https://doi.org/10.2337/diacare.21.11.1824

  5. Lassmann-Vague, V

    1. Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
      V Lassmann-Vague, M SanMarco, P J LeJeune, C Alessis, P Vague and P Belicar
      Diabetes Care 1998 Nov; 21 (11): 2041-2044. https://doi.org/10.2337/diacare.21.11.2041

  6. Lauritzen, E

    1. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
      K Rossing, P Jacobsen, P Rossing, E Lauritzen, H Lund-Andersen and H H Parving
      Diabetes Care 1998 Nov; 21 (11): 2007-2015. https://doi.org/10.2337/diacare.21.11.2007

  7. Laws, A

    1. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
      J T Dubuisson, L E Wagenknecht, R B D'Agostino, S M Haffner, M Rewers, M F Saad, A Laws and D M Herrington
      Diabetes Care 1998 Nov; 21 (11): 1790-1796. https://doi.org/10.2337/diacare.21.11.1790

  8. Lee, H L

    1. Fasting plasma glucose in screening for diabetes in the Taiwanese population.
      C J Chang, J S Wu, F H Lu, H L Lee, Y C Yang and M J Wen
      Diabetes Care 1998 Nov; 21 (11): 1856-1860. https://doi.org/10.2337/diacare.21.11.1856

  9. Lee, Y J

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  10. LeJeune, P J

    1. Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
      V Lassmann-Vague, M SanMarco, P J LeJeune, C Alessis, P Vague and P Belicar
      Diabetes Care 1998 Nov; 21 (11): 2041-2044. https://doi.org/10.2337/diacare.21.11.2041

  11. Le Prieur, N

    1. Clinical and statistical evaluation of self-monitoring blood glucose meters.
      J Y Poirier, N Le Prieur, L Campion, I Guilhem, H Allannic and D Maugendre
      Diabetes Care 1998 Nov; 21 (11): 1919-1924. https://doi.org/10.2337/diacare.21.11.1919

  12. Libman, I M

    1. Islet cell autoimmunity in white and black children and adolescents with IDDM.
      I M Libman, M Pietropaolo, M Trucco, J S Dorman, R E LaPorte and D Becker
      Diabetes Care 1998 Nov; 21 (11): 1824-1827. https://doi.org/10.2337/diacare.21.11.1824

  13. Lin, X

    1. Differential effects of BMI on diabetes risk among black and white Americans.
      H E Resnick, P Valsania, J B Halter and X Lin
      Diabetes Care 1998 Nov; 21 (11): 1828-1835. https://doi.org/10.2337/diacare.21.11.1828

  14. Lindholm, A

    1. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
      P D Home, A Lindholm, B Hylleberg and P Round
      Diabetes Care 1998 Nov; 21 (11): 1904-1909. https://doi.org/10.2337/diacare.21.11.1904

  15. Lobefalo, L

    1. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
      L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese, P E Gallenga and F Chiarelli
      Diabetes Care 1998 Nov; 21 (11): 2003-2006. https://doi.org/10.2337/diacare.21.11.2003

  16. Lobón, J A

    1. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
      V Sánchez-Margalet, J A Lobón, A González, M L Fernández-Soto, F Escobar-Jiménez and R Goberna
      Diabetes Care 1998 Nov; 21 (11): 1951-1954. https://doi.org/10.2337/diacare.21.11.1951

  17. López-Alvarenga, J C

    1. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
      F J Gómez-Pérez, C A Aguilar-Salinas, J C López-Alvarenga, J Perez-Jauregui, L E Guillen-Pineda and J A Rull
      Diabetes Care 1998 Nov; 21 (11): 1886-1888. https://doi.org/10.2337/diacare.21.11.1886

  18. Lorenz, R

    1. The problem with intensive therapy.
      R Lorenz
      Diabetes Care 1998 Nov; 21 (11): 2021-2022. https://doi.org/10.2337/diacare.21.11.2021

  19. Lu, F H

    1. Fasting plasma glucose in screening for diabetes in the Taiwanese population.
      C J Chang, J S Wu, F H Lu, H L Lee, Y C Yang and M J Wen
      Diabetes Care 1998 Nov; 21 (11): 1856-1860. https://doi.org/10.2337/diacare.21.11.1856

  20. Lucas, C P

    1. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
      R B Goldberg, D Einhorn, C P Lucas, M S Rendell, P Damsbo, W C Huang, P Strange and R G Brodows
      Diabetes Care 1998 Nov; 21 (11): 1897-1903. https://doi.org/10.2337/diacare.21.11.1897

  21. Lucena, M

    1. Acarbose-associated hepatotoxicity.
      R J Andrade, M Lucena, J L Vega, M Torres, F J Salmerón, V Bellot, M D García-Escaño and P Moreno
      Diabetes Care 1998 Nov; 21 (11): 2029-2030. https://doi.org/10.2337/diacare.21.11.2029

  22. Lund-Andersen, H

    1. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
      K Rossing, P Jacobsen, P Rossing, E Lauritzen, H Lund-Andersen and H H Parving
      Diabetes Care 1998 Nov; 21 (11): 2007-2015. https://doi.org/10.2337/diacare.21.11.2007

  23. Luzio, S D

    1. Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
      R Playle, R L Ollerton, F D Dunstan, W D Evans, A Burch, S D Luzio and D R Owens
      Diabetes Care 1998 Nov; 21 (11): 1893-1896. https://doi.org/10.2337/diacare.21.11.1893

M

  1. Mahler, R

    1. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
      C Meyer, R Grossmann, A Mitrakou, R Mahler, T Veneman, J Gerich and R G Bretzel
      Diabetes Care 1998 Nov; 21 (11): 1960-1966. https://doi.org/10.2337/diacare.21.11.1960

  2. Maruyama, T

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

  3. Mastropasqua, L

    1. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
      L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese, P E Gallenga and F Chiarelli
      Diabetes Care 1998 Nov; 21 (11): 2003-2006. https://doi.org/10.2337/diacare.21.11.2003

  4. Maugendre, D

    1. Clinical and statistical evaluation of self-monitoring blood glucose meters.
      J Y Poirier, N Le Prieur, L Campion, I Guilhem, H Allannic and D Maugendre
      Diabetes Care 1998 Nov; 21 (11): 1919-1924. https://doi.org/10.2337/diacare.21.11.1919

  5. McLaren, M

    1. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
      T A Elhadd, F Khan, G Kirk, M McLaren, R W Newton, S A Greene and J J Belch
      Diabetes Care 1998 Nov; 21 (11): 1990-1996. https://doi.org/10.2337/diacare.21.11.1990

  6. McPartlin, J M

    1. Plasma homocysteine concentrations in patients with type 1 diabetes.
      C C Cronin, J M McPartlin, D G Barry, J B Ferriss, J M Scott and D G Weir
      Diabetes Care 1998 Nov; 21 (11): 1843-1847. https://doi.org/10.2337/diacare.21.11.1843

  7. Mercier, J

    1. Association between fibrinogen levels and insulin resistance.
      E Raynaud, J F Brun, A Perez-Martin and J Mercier
      Diabetes Care 1998 Nov; 21 (11): 2040-2041. https://doi.org/10.2337/diacare.21.11.2040

  8. Metzger, B E

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  9. Meyer, C

    1. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
      C Meyer, R Grossmann, A Mitrakou, R Mahler, T Veneman, J Gerich and R G Bretzel
      Diabetes Care 1998 Nov; 21 (11): 1960-1966. https://doi.org/10.2337/diacare.21.11.1960

  10. Miller, J

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  11. Mills, J L

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  12. Mitrakou, A

    1. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
      C Meyer, R Grossmann, A Mitrakou, R Mahler, T Veneman, J Gerich and R G Bretzel
      Diabetes Care 1998 Nov; 21 (11): 1960-1966. https://doi.org/10.2337/diacare.21.11.1960
    2. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
      M T Korytkowski, M Mokan, T F Veneman, A Mitrakou, P E Cryer and J E Gerich
      Diabetes Care 1998 Nov; 21 (11): 1939-1943. https://doi.org/10.2337/diacare.21.11.1939

  13. Mohan, V

    1. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
      V Mohan, R Deepa, S P Haranath, G Premalatha, M Rema, N G Sastry and E A Enas
      Diabetes Care 1998 Nov; 21 (11): 1819-1823. https://doi.org/10.2337/diacare.21.11.1819

  14. Mokan, M

    1. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
      M T Korytkowski, M Mokan, T F Veneman, A Mitrakou, P E Cryer and J E Gerich
      Diabetes Care 1998 Nov; 21 (11): 1939-1943. https://doi.org/10.2337/diacare.21.11.1939

  15. Morange, P

    1. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
      M A Charles, P Morange, E Eschwège, P André, P Vague and I Juhan-Vague
      Diabetes Care 1998 Nov; 21 (11): 1967-1972. https://doi.org/10.2337/diacare.21.11.1967

  16. Moreno, P

    1. Acarbose-associated hepatotoxicity.
      R J Andrade, M Lucena, J L Vega, M Torres, F J Salmerón, V Bellot, M D García-Escaño and P Moreno
      Diabetes Care 1998 Nov; 21 (11): 2029-2030. https://doi.org/10.2337/diacare.21.11.2029

  17. Morgese, G

    1. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
      L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese, P E Gallenga and F Chiarelli
      Diabetes Care 1998 Nov; 21 (11): 2003-2006. https://doi.org/10.2337/diacare.21.11.2003

  18. Morii, H

    1. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
      H Taniwaki, Y Nishizawa, T Kawagishi, E Ishimura, M Emoto, T Okamura, Y Okuno and H Morii
      Diabetes Care 1998 Nov; 21 (11): 1848-1855. https://doi.org/10.2337/diacare.21.11.1848

  19. Morimoto, J

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

  20. Moses, J

    1. Gestational diabetes: do lean young caucasian women need to be tested?
      R G Moses, J Moses and W S Davis
      Diabetes Care 1998 Nov; 21 (11): 1803-1806. https://doi.org/10.2337/diacare.21.11.1803

  21. Moses, M

    1. The 75-g glucose tolerance test in pregnancy: a reference range determined on a low-risk population and related to selected pregnancy outcomes.
      R G Moses, M Moses, K G Russell and G M Schier
      Diabetes Care 1998 Nov; 21 (11): 1807-1811. https://doi.org/10.2337/diacare.21.11.1807

  22. Moses, R G

    1. Gestational diabetes: do lean young caucasian women need to be tested?
      R G Moses, J Moses and W S Davis
      Diabetes Care 1998 Nov; 21 (11): 1803-1806. https://doi.org/10.2337/diacare.21.11.1803
    2. The 75-g glucose tolerance test in pregnancy: a reference range determined on a low-risk population and related to selected pregnancy outcomes.
      R G Moses, M Moses, K G Russell and G M Schier
      Diabetes Care 1998 Nov; 21 (11): 1807-1811. https://doi.org/10.2337/diacare.21.11.1807

  23. Mourlhon, C

    1. Consequences of metformin intoxication.
      J D Lalau, C Mourlhon, A Bergeret and C Lacroix
      Diabetes Care 1998 Nov; 21 (11): 2036-2037. https://doi.org/10.2337/diacare.21.11.2036

  24. Mumcuoglu, K Y

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

N

  1. Nauck, M A

    1. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
      M A Nauck, A Sauerwald, R Ritzel, J J Holst and W Schmiegel
      Diabetes Care 1998 Nov; 21 (11): 1925-1931. https://doi.org/10.2337/diacare.21.11.1925

  2. Newton, R W

    1. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
      T A Elhadd, F Khan, G Kirk, M McLaren, R W Newton, S A Greene and J J Belch
      Diabetes Care 1998 Nov; 21 (11): 1990-1996. https://doi.org/10.2337/diacare.21.11.1990

  3. Nierop, P R

    1. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
      A Elhendy, R T van Domburg, D Poldermans, J J Bax, P R Nierop, M L Geleijnse and J R Roelandt
      Diabetes Care 1998 Nov; 21 (11): 1797-1802. https://doi.org/10.2337/diacare.21.11.1797

  4. Nishizawa, Y

    1. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
      H Taniwaki, Y Nishizawa, T Kawagishi, E Ishimura, M Emoto, T Okamura, Y Okuno and H Morii
      Diabetes Care 1998 Nov; 21 (11): 1848-1855. https://doi.org/10.2337/diacare.21.11.1848

  5. Niskanen, L

    1. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
      L Niskanen, A Turpeinen, I Penttilä and M I Uusitupa
      Diabetes Care 1998 Nov; 21 (11): 1861-1869. https://doi.org/10.2337/diacare.21.11.1861

O

  1. Ohsawa, N

    1. Impaired insulin secretion in Japanese diabetic subjects with an A-to-G mutation at nucleotide 8296 of the mitochondrial DNA in tRNA(Lys)
      K Kameoka, H Isotani, K Tanaka, H Kitaoka and N Ohsawa
      Diabetes Care 1998 Nov; 21 (11): 2034-2035. https://doi.org/10.2337/diacare.21.11.2034

  2. Okamura, T

    1. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
      H Taniwaki, Y Nishizawa, T Kawagishi, E Ishimura, M Emoto, T Okamura, Y Okuno and H Morii
      Diabetes Care 1998 Nov; 21 (11): 1848-1855. https://doi.org/10.2337/diacare.21.11.1848

  3. Okosun, I S

    1. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans.
      I S Okosun, R S Cooper, C N Rotimi, B Osotimehin and T Forrester
      Diabetes Care 1998 Nov; 21 (11): 1836-1842. https://doi.org/10.2337/diacare.21.11.1836

  4. Okuno, Y

    1. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
      H Taniwaki, Y Nishizawa, T Kawagishi, E Ishimura, M Emoto, T Okamura, Y Okuno and H Morii
      Diabetes Care 1998 Nov; 21 (11): 1848-1855. https://doi.org/10.2337/diacare.21.11.1848

  5. Ollerton, R L

    1. Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
      R Playle, R L Ollerton, F D Dunstan, W D Evans, A Burch, S D Luzio and D R Owens
      Diabetes Care 1998 Nov; 21 (11): 1893-1896. https://doi.org/10.2337/diacare.21.11.1893

  6. Osotimehin, B

    1. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans.
      I S Okosun, R S Cooper, C N Rotimi, B Osotimehin and T Forrester
      Diabetes Care 1998 Nov; 21 (11): 1836-1842. https://doi.org/10.2337/diacare.21.11.1836

  7. Ovalle, F

    1. Metformin lowers lipoprotein(a) levels.
      D S Bell and F Ovalle
      Diabetes Care 1998 Nov; 21 (11): 2028. https://doi.org/10.2337/diacare.21.11.2028b
    2. Troglitazone interferes with gemfibrozil's lipid-lowering action.
      D S Bell and F Ovalle
      Diabetes Care 1998 Nov; 21 (11): 2028-2029. https://doi.org/10.2337/diacare.21.11.2028a

  8. Owens, D R

    1. Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
      R Playle, R L Ollerton, F D Dunstan, W D Evans, A Burch, S D Luzio and D R Owens
      Diabetes Care 1998 Nov; 21 (11): 1893-1896. https://doi.org/10.2337/diacare.21.11.1893

  9. Ozawa, Y

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

P

  1. Parazzini, F

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  2. Park, E

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  3. Parving, H H

    1. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
      K Rossing, P Jacobsen, P Rossing, E Lauritzen, H Lund-Andersen and H H Parving
      Diabetes Care 1998 Nov; 21 (11): 2007-2015. https://doi.org/10.2337/diacare.21.11.2007

  4. Penttilä, I

    1. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
      L Niskanen, A Turpeinen, I Penttilä and M I Uusitupa
      Diabetes Care 1998 Nov; 21 (11): 1861-1869. https://doi.org/10.2337/diacare.21.11.1861

  5. Perez-Jauregui, J

    1. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
      F J Gómez-Pérez, C A Aguilar-Salinas, J C López-Alvarenga, J Perez-Jauregui, L E Guillen-Pineda and J A Rull
      Diabetes Care 1998 Nov; 21 (11): 1886-1888. https://doi.org/10.2337/diacare.21.11.1886

  6. Perez-Martin, A

    1. Association between fibrinogen levels and insulin resistance.
      E Raynaud, J F Brun, A Perez-Martin and J Mercier
      Diabetes Care 1998 Nov; 21 (11): 2040-2041. https://doi.org/10.2337/diacare.21.11.2040

  7. Pettitt, D J

    1. Gestational diabetes mellitus: who to test. How to test.
      D J Pettitt
      Diabetes Care 1998 Nov; 21 (11): 1789. https://doi.org/10.2337/diacare.21.11.1789

  8. Pietropaolo, M

    1. Islet cell autoimmunity in white and black children and adolescents with IDDM.
      I M Libman, M Pietropaolo, M Trucco, J S Dorman, R E LaPorte and D Becker
      Diabetes Care 1998 Nov; 21 (11): 1824-1827. https://doi.org/10.2337/diacare.21.11.1824

  9. Playle, R

    1. Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
      R Playle, R L Ollerton, F D Dunstan, W D Evans, A Burch, S D Luzio and D R Owens
      Diabetes Care 1998 Nov; 21 (11): 1893-1896. https://doi.org/10.2337/diacare.21.11.1893

  10. Poirier, J Y

    1. Clinical and statistical evaluation of self-monitoring blood glucose meters.
      J Y Poirier, N Le Prieur, L Campion, I Guilhem, H Allannic and D Maugendre
      Diabetes Care 1998 Nov; 21 (11): 1919-1924. https://doi.org/10.2337/diacare.21.11.1919

  11. Poldermans, D

    1. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
      A Elhendy, R T van Domburg, D Poldermans, J J Bax, P R Nierop, M L Geleijnse and J R Roelandt
      Diabetes Care 1998 Nov; 21 (11): 1797-1802. https://doi.org/10.2337/diacare.21.11.1797

  12. Pouwer, F

    1. Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire.
      F Pouwer, F J Snoek and R J Heine
      Diabetes Care 1998 Nov; 21 (11): 2039. https://doi.org/10.2337/diacare.21.11.2039b

  13. Premalatha, G

    1. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
      V Mohan, R Deepa, S P Haranath, G Premalatha, M Rema, N G Sastry and E A Enas
      Diabetes Care 1998 Nov; 21 (11): 1819-1823. https://doi.org/10.2337/diacare.21.11.1819

R

  1. Rauhaus, M

    1. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
      L Heinemann, C Weyer, M Rauhaus, S Heinrichs and T Heise
      Diabetes Care 1998 Nov; 21 (11): 1910-1914. https://doi.org/10.2337/diacare.21.11.1910

  2. Raynaud, E

    1. Association between fibrinogen levels and insulin resistance.
      E Raynaud, J F Brun, A Perez-Martin and J Mercier
      Diabetes Care 1998 Nov; 21 (11): 2040-2041. https://doi.org/10.2337/diacare.21.11.2040

  3. Raz, I

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  4. Redmon, J B

    1. Hypoglycemia after pancreas transplantation.
      J B Redmon, A U Teuscher and R P Robertson
      Diabetes Care 1998 Nov; 21 (11): 1944-1950. https://doi.org/10.2337/diacare.21.11.1944

  5. Rema, M

    1. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
      V Mohan, R Deepa, S P Haranath, G Premalatha, M Rema, N G Sastry and E A Enas
      Diabetes Care 1998 Nov; 21 (11): 1819-1823. https://doi.org/10.2337/diacare.21.11.1819

  6. Rendell, M S

    1. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
      R B Goldberg, D Einhorn, C P Lucas, M S Rendell, P Damsbo, W C Huang, P Strange and R G Brodows
      Diabetes Care 1998 Nov; 21 (11): 1897-1903. https://doi.org/10.2337/diacare.21.11.1897

  7. Resnick, H E

    1. Differential effects of BMI on diabetes risk among black and white Americans.
      H E Resnick, P Valsania, J B Halter and X Lin
      Diabetes Care 1998 Nov; 21 (11): 1828-1835. https://doi.org/10.2337/diacare.21.11.1828

  8. Rewers, M

    1. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
      J T Dubuisson, L E Wagenknecht, R B D'Agostino, S M Haffner, M Rewers, M F Saad, A Laws and D M Herrington
      Diabetes Care 1998 Nov; 21 (11): 1790-1796. https://doi.org/10.2337/diacare.21.11.1790
    2. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
      L E Wagenknecht, R B D'Agostino, S M Haffner, P J Savage and M Rewers
      Diabetes Care 1998 Nov; 21 (11): 1812-1818. https://doi.org/10.2337/diacare.21.11.1812

  9. Ritzel, R

    1. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
      M A Nauck, A Sauerwald, R Ritzel, J J Holst and W Schmiegel
      Diabetes Care 1998 Nov; 21 (11): 1925-1931. https://doi.org/10.2337/diacare.21.11.1925

  10. Robertson, R P

    1. Hypoglycemia after pancreas transplantation.
      J B Redmon, A U Teuscher and R P Robertson
      Diabetes Care 1998 Nov; 21 (11): 1944-1950. https://doi.org/10.2337/diacare.21.11.1944

  11. Roelandt, J R

    1. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
      A Elhendy, R T van Domburg, D Poldermans, J J Bax, P R Nierop, M L Geleijnse and J R Roelandt
      Diabetes Care 1998 Nov; 21 (11): 1797-1802. https://doi.org/10.2337/diacare.21.11.1797

  12. Rose, M

    1. Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
      M Rose, U Burkert, G Scholler, T Schirop, G Danzer and B F Klapp
      Diabetes Care 1998 Nov; 21 (11): 1876-1885. https://doi.org/10.2337/diacare.21.11.1876

  13. Rossing, K

    1. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
      K Rossing, P Jacobsen, P Rossing, E Lauritzen, H Lund-Andersen and H H Parving
      Diabetes Care 1998 Nov; 21 (11): 2007-2015. https://doi.org/10.2337/diacare.21.11.2007

  14. Rossing, P

    1. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
      K Rossing, P Jacobsen, P Rossing, E Lauritzen, H Lund-Andersen and H H Parving
      Diabetes Care 1998 Nov; 21 (11): 2007-2015. https://doi.org/10.2337/diacare.21.11.2007

  15. Rotimi, C N

    1. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans.
      I S Okosun, R S Cooper, C N Rotimi, B Osotimehin and T Forrester
      Diabetes Care 1998 Nov; 21 (11): 1836-1842. https://doi.org/10.2337/diacare.21.11.1836

  16. Round, P

    1. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
      P D Home, A Lindholm, B Hylleberg and P Round
      Diabetes Care 1998 Nov; 21 (11): 1904-1909. https://doi.org/10.2337/diacare.21.11.1904

  17. Rull, J A

    1. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
      F J Gómez-Pérez, C A Aguilar-Salinas, J C López-Alvarenga, J Perez-Jauregui, L E Guillen-Pineda and J A Rull
      Diabetes Care 1998 Nov; 21 (11): 1886-1888. https://doi.org/10.2337/diacare.21.11.1886

  18. Russell, K G

    1. The 75-g glucose tolerance test in pregnancy: a reference range determined on a low-risk population and related to selected pregnancy outcomes.
      R G Moses, M Moses, K G Russell and G M Schier
      Diabetes Care 1998 Nov; 21 (11): 1807-1811. https://doi.org/10.2337/diacare.21.11.1807

S

  1. Saad, M F

    1. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
      J T Dubuisson, L E Wagenknecht, R B D'Agostino, S M Haffner, M Rewers, M F Saad, A Laws and D M Herrington
      Diabetes Care 1998 Nov; 21 (11): 1790-1796. https://doi.org/10.2337/diacare.21.11.1790

  2. Sahin, G

    1. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan.
      A R Uysal, M F Erdoğan, G Sahin, N Kamel and G Erdoğan
      Diabetes Care 1998 Nov; 21 (11): 2033-2034. https://doi.org/10.2337/diacare.21.11.2033

  3. Salmerón, F J

    1. Acarbose-associated hepatotoxicity.
      R J Andrade, M Lucena, J L Vega, M Torres, F J Salmerón, V Bellot, M D García-Escaño and P Moreno
      Diabetes Care 1998 Nov; 21 (11): 2029-2030. https://doi.org/10.2337/diacare.21.11.2029

  4. Saloranta, C

    1. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
      C M Forsblom, P H Groop, A Ekstrand, K J Tötterman, T Sane, C Saloranta and L Groop
      Diabetes Care 1998 Nov; 21 (11): 1932-1938. https://doi.org/10.2337/diacare.21.11.1932

  5. Sánchez-Margalet, V

    1. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
      V Sánchez-Margalet, J A Lobón, A González, M L Fernández-Soto, F Escobar-Jiménez and R Goberna
      Diabetes Care 1998 Nov; 21 (11): 1951-1954. https://doi.org/10.2337/diacare.21.11.1951

  6. Sane, T

    1. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
      C M Forsblom, P H Groop, A Ekstrand, K J Tötterman, T Sane, C Saloranta and L Groop
      Diabetes Care 1998 Nov; 21 (11): 1932-1938. https://doi.org/10.2337/diacare.21.11.1932

  7. SanMarco, M

    1. Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
      V Lassmann-Vague, M SanMarco, P J LeJeune, C Alessis, P Vague and P Belicar
      Diabetes Care 1998 Nov; 21 (11): 2041-2044. https://doi.org/10.2337/diacare.21.11.2041

  8. Santeusanio, F

    1. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
      D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
      Diabetes Care 1998 Nov; 21 (11): 1973-1977. https://doi.org/10.2337/diacare.21.11.1973

  9. Saruta, T

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

  10. Sastry, N G

    1. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
      V Mohan, R Deepa, S P Haranath, G Premalatha, M Rema, N G Sastry and E A Enas
      Diabetes Care 1998 Nov; 21 (11): 1819-1823. https://doi.org/10.2337/diacare.21.11.1819

  11. Sauerwald, A

    1. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
      M A Nauck, A Sauerwald, R Ritzel, J J Holst and W Schmiegel
      Diabetes Care 1998 Nov; 21 (11): 1925-1931. https://doi.org/10.2337/diacare.21.11.1925

  12. Savage, P J

    1. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
      L E Wagenknecht, R B D'Agostino, S M Haffner, P J Savage and M Rewers
      Diabetes Care 1998 Nov; 21 (11): 1812-1818. https://doi.org/10.2337/diacare.21.11.1812

  13. Schernthaner, G

    1. Magnesium supplementation in type 2 diabetes.
      N Eibl, C Schnack and G Schernthaner
      Diabetes Care 1998 Nov; 21 (11): 2031-2032. https://doi.org/10.2337/diacare.21.11.2031

  14. Schier, G M

    1. The 75-g glucose tolerance test in pregnancy: a reference range determined on a low-risk population and related to selected pregnancy outcomes.
      R G Moses, M Moses, K G Russell and G M Schier
      Diabetes Care 1998 Nov; 21 (11): 1807-1811. https://doi.org/10.2337/diacare.21.11.1807

  15. Schirop, T

    1. Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
      M Rose, U Burkert, G Scholler, T Schirop, G Danzer and B F Klapp
      Diabetes Care 1998 Nov; 21 (11): 1876-1885. https://doi.org/10.2337/diacare.21.11.1876

  16. Schlundt, D

    1. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
      B P Kovatchev, D J Cox, L A Gonder-Frederick, D Young-Hyman, D Schlundt and W Clarke
      Diabetes Care 1998 Nov; 21 (11): 1870-1875. https://doi.org/10.2337/diacare.21.11.1870

  17. Schmiegel, W

    1. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
      M A Nauck, A Sauerwald, R Ritzel, J J Holst and W Schmiegel
      Diabetes Care 1998 Nov; 21 (11): 1925-1931. https://doi.org/10.2337/diacare.21.11.1925

  18. Schnack, C

    1. Magnesium supplementation in type 2 diabetes.
      N Eibl, C Schnack and G Schernthaner
      Diabetes Care 1998 Nov; 21 (11): 2031-2032. https://doi.org/10.2337/diacare.21.11.2031

  19. Scholler, G

    1. Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
      M Rose, U Burkert, G Scholler, T Schirop, G Danzer and B F Klapp
      Diabetes Care 1998 Nov; 21 (11): 1876-1885. https://doi.org/10.2337/diacare.21.11.1876

  20. Schulman, H

    1. Maggot therapy for the treatment of diabetic foot ulcers.
      K Y Mumcuoglu, A Ingber, L Gilead, J Stessman, R Friedmann, H Schulman, H Bichucher, I Ioffe-Uspensky, J Miller, R Galun and I Raz
      Diabetes Care 1998 Nov; 21 (11): 2030-2031. https://doi.org/10.2337/diacare.21.11.2030

  21. Scott, J M

    1. Plasma homocysteine concentrations in patients with type 1 diabetes.
      C C Cronin, J M McPartlin, D G Barry, J B Ferriss, J M Scott and D G Weir
      Diabetes Care 1998 Nov; 21 (11): 1843-1847. https://doi.org/10.2337/diacare.21.11.1843

  22. Scott, R B

    1. Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes.
      K A Fraser-Reynolds, J D Butzner, D K Stephure, R A Trussell and R B Scott
      Diabetes Care 1998 Nov; 21 (11): 1985-1989. https://doi.org/10.2337/diacare.21.11.1985

  23. Shaw, J E

    1. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy.
      J E Shaw, C H van Schie, A L Carrington, C A Abbott and A J Boulton
      Diabetes Care 1998 Nov; 21 (11): 1955-1959. https://doi.org/10.2337/diacare.21.11.1955

  24. Shimada, A

    1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
      J Morimoto, T Maruyama, A Kasuga, Y Ozawa, A Kobayashi, S Funakoshi, R Iwasaki, Y Suzuki, A Shimada and T Saruta
      Diabetes Care 1998 Nov; 21 (11): 2037-2039. https://doi.org/10.2337/diacare.21.11.2037

  25. Simpson, J L

    1. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
      L Jovanovic, B E Metzger, R H Knopp, M R conley, E Park, Y J Lee, J L Simpson, L Holmes, J H Aarons and J L Mills
      Diabetes Care 1998 Nov; 21 (11): 1978-1984. https://doi.org/10.2337/diacare.21.11.1978

  26. Snoek, F J

    1. Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire.
      F Pouwer, F J Snoek and R J Heine
      Diabetes Care 1998 Nov; 21 (11): 2039. https://doi.org/10.2337/diacare.21.11.2039b

  27. Steiner, G

    1. Micronized fenofibrate in the management of dyslipidemia.